GENOCEA BIOSCIENCES INC's ticker is GNCA and the CUSIP is 372427401. A total of 34 filers reported holding GENOCEA BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $716,000 | +148.6% | 312,666 | +149.5% | 0.11% | +84.5% |
| Q2 2020 | $288,000 | -62.0% | 125,312 | -71.5% | 0.06% | -81.6% |
| Q1 2020 | $757,000 | -32.0% | 440,274 | -18.2% | 0.32% | +1.9% |
| Q4 2019 | $1,114,000 | -19.5% | 538,359 | +12.8% | 0.31% | -58.6% |
| Q3 2019 | $1,384,000 | -28.5% | 477,351 | -3.4% | 0.75% | -69.4% |
| Q2 2019 | $1,937,000 | – | 494,175 | – | 2.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 375,000 | $720,000 | 29.91% |
| Polaris Venture Management Co. V, L.L.C. | 197,345 | $379,000 | 2.69% |
| COMMODORE CAPITAL LP | 3,079,756 | $5,913,000 | 1.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,972,056 | $3,786,000 | 0.46% |
| BVF INC/IL | 4,012,404 | $7,704,000 | 0.30% |
| NEA Management Company, LLC | 10,376,936 | $19,924,000 | 0.24% |
| Avoro Capital Advisors LLC | 5,084,184 | $9,762,000 | 0.15% |
| Boxer Capital, LLC | 1,134,453 | $2,178,000 | 0.08% |
| Ikarian Capital, LLC | 196,821 | $377,000 | 0.03% |
| Point72 Asset Management, L.P. | 2,652,974 | $5,094,000 | 0.02% |